Clinical trial
As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild…
NCT00382889 · Chiesi Farmaceutici S.p.A., Industry · Completed
Key facts
| NCT number | NCT00382889 |
|---|---|
| Title | As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma |
| Official title | Multinational, Double Blind, Randomised, Parallel Group Study on the Therapeutic Efficacy and Safety of Beclomethasone Dipropionate 250 mg Combined With Salbutamol 100 mg in the Treatment of Patients With Mild Persistent Asthma. |
| Lead sponsor | Chiesi Farmaceutici S.p.A., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | beclomethasone/salbutamol combination, beclomethasone, salbutamol |
| Enrollment | 480 |
| Start date | Aug 1, 2002 |
| Completion | Sep 1, 2004 |
| First posted | Oct 2, 2006 |
| Last update posted | Aug 3, 2020 |
| Countries | Austria, Italy, Poland, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: